Oncotarget

Research Papers:

Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages

Chih-Feng Chian, Yi-Ting Hwang, Harn-Jing Terng, Shih-Chun Lee, Tsui-Yi Chao, Hung Chang, Ching-Liang Ho, Yi-Ying Wu and Wann-Cherng Perng _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:50582-50595. https://doi.org/10.18632/oncotarget.10558

Metrics: PDF 1299 views  |   HTML 1667 views  |   ?  


Abstract

Chih-Feng Chian1, Yi-Ting Hwang2, Harn-Jing Terng3, Shih-Chun Lee4, Tsui-Yi Chao5,7, Hung Chang4, Ching-Liang Ho6, Yi-Ying Wu6, Wann-Cherng Perng1

1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC

2Department of Statistics, National Taipei University, Taipei, Taiwan, ROC

3Advpharma, Inc., Taipei, Taiwan, ROC

4Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC

5Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan, ROC

6Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC

7Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, ROC

Correspondence to:

Wann-Cherng Perng, email: wperng@ms27.hinet.net

Keywords: circulating tumor cells, gene expression profiling, non-small cell lung cancer

Received: July 17, 2015    Accepted: June 29, 2016    Published: July 13, 2016

ABSTRACT

Peripheral blood mononuclear cell (PBMC)-derived gene signatures were investigated for their potential use in the early detection of non-small cell lung cancer (NSCLC). In our study, 187 patients with NSCLC and 310 age- and gender-matched controls, and an independent set containing 29 patients for validation were included. Eight significant NSCLC-associated genes were identified, including DUSP6, EIF2S3, GRB2, MDM2, NF1, POLDIP2, RNF4, and WEE1. The logistic model containing these significant markers was able to distinguish subjects with NSCLC from controls with an excellent performance, 80.7% sensitivity, 90.6% specificity, and an area under the receiver operating characteristic curve (AUC) of 0.924. Repeated random sub-sampling for 100 times was used to validate the performance of classification training models with an average AUC of 0.92. Additional cross-validation using the independent set resulted in the sensitivity 75.86%. Furthermore, six age/gender-dependent genes: CPEB4, EIF2S3, GRB2, MCM4, RNF4, and STAT2 were identified using age and gender stratification approach. STAT2 and WEE1 were explored as stage-dependent using stage-stratified subpopulation. We conclude that these logistic models using different signatures for total and stratified samples are potential complementary tools for assessing the risk of NSCLC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 10558